Oncolytic virus-initiated protective immunity against prostate cancer
/in International Publications, Newcastle Disease Virus, Prostate Cancer /von 2011-01-18 / Mol. Ther. 2011 Apr;19(4):797-804KNK437, a benzylidene lactam compound, sensitises prostate cancer cells to the apoptotic effect of hyperthermia
/in Hyperthermia, International Publications, Prostate Cancer /von 2011-01-04 / Int J Hyperthermia 2011;27(1):63-73Sipuleucel-T: in metastatic castration-resistant prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-01-01 / Drugs 2011 Jan;71(1):101-8Dendritic cell-based immunotherapy for prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2010-11-04 / Clin. Dev. Immunol. 2010;2010:517493RIG-I helicase-independent pathway in sendai virus-activated dendritic cells is critical for preventing lung metastasis of AT6.3 prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2010-11-01 / Neoplasia 2010 Nov;12(11):906-14Hyperthermia combined with radiation for the treatment of locally advanced prostate cancer: long-term results from Dana-Farber Cancer Institute study 94-153
/in Hyperthermia, International Publications, Prostate Cancer /von 2010-09-30 / Cancer 2011 Feb;117(3):510-6Measurement and mathematical modeling of thermally induced injury and heat shock protein expression kinetics in normal and cancerous prostate cells
/in Hyperthermia, International Publications, Prostate Cancer /von 2010-09-21 / Int J Hyperthermia 2010;26(8):748-64Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2010-09-01 / PLoS ONE 2010 Sep;5(9)[Auto-dendritic cell vaccines pulsed with PSA, PSMA and PAP peptides for hormone-refractory prostate cancer]
/in Dendritic Cells, International Publications, Prostate Cancer /von 2010-08-01 / Zhonghua Nan Ke Xue 2010 Aug;16(8):698-704IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de